Forte Biosciences, Inc.
FBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35,478 | -$31,476 | -$13,879 | -$21,708 |
| Dep. & Amort. | $39 | $9 | $0 | $36 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,095 | $3,284 | $4,015 | $0 |
| Change in WC | $1,757 | -$392 | $1,679 | $720 |
| Other Non-Cash | -$158 | -$131 | $0 | $4,275 |
| Operating Cash Flow | -$30,745 | -$28,706 | -$8,185 | -$16,677 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$37 | -$88 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$35,956 | -$9,965 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $10,100 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$35,993 | $47 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $53,000 | $24,744 | $7,229 | $62 |
| Stock Repurch. | -$1 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,142 | -$28 | $12 | -$106 |
| Financing Cash Flow | $51,857 | $24,684 | $7,241 | -$44 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14,881 | -$3,975 | -$944 | -$16,721 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37,125 | $41,100 | $42,044 | $58,765 |
| End Cash | $22,244 | $37,125 | $41,100 | $42,044 |
| Free Cash Flow | -$30,782 | -$28,794 | -$8,185 | -$16,677 |